Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19

BACKGROUND: Antithrombotic guidance statements for hospitalized patients with coronavirus disease 2019 (COVID‐19) suggest a universal thromboprophylactic strategy with potential to escalate doses in high‐risk patients. To date, no clear approach exists to discriminate patients at high risk for venou...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Res Pract Thromb Haemost
Huvudupphovsmän: Spyropoulos, Alex C., Cohen, Stuart L., Gianos, Eugenia, Kohn, Nina, Giannis, Dimitrios, Chatterjee, Saurav, Goldin, Mark, Lesser, Marty, Coppa, Kevin, Hirsch, Jamie S., McGinn, Thomas, Barish, Matthew A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley and Sons Inc. 2021
Ämnen:
Original Articles ‐ Thrombosis
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7938615/
https://ncbi.nlm.nih.gov/pubmed/33733028
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12486
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk